Cybin Inc. Common Shares (CYBN)

Cybin Inc is a biotechnology company focused on developing innovative psychedelic-based therapeutic solutions to address various mental health disorders

The company is engaged in research and clinical development of psychedelic compounds, aiming to enhance mental health treatment options through advanced drug formulations and delivery methods. By leveraging the potential of psychedelics, Cybin strives to provide patients with new avenues for healing and improved quality of life, while also working to advance the understanding and acceptance of psychedelic therapies in mainstream medicine.